Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 42385-801

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate (NDC 42385-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ertdf-emt-structure.jpg (Ertdf Emt Structure)

Chemical structure diagram of emtricitabine, showing its molecular arrangement with nitrogen, oxygen, sulfur, and fluorine atoms connected in a specific pattern.*

FDA Label Image

Ertdf-figure-1.jpg (Ertdf Figure 1)

A partial text panel listing side effects associated with the drug emtricitabine, rilpivirine and tenofovir disoproxil fumarate. The visible text includes symptoms such as fever, skin blisters, mouth sores, redness or swelling of the eyes (conjunctivitis), swelling of the face, lips, mouth, tongue or throat, trouble breathing or swallowing, pain on the right side of the stomach (abdominal area), and dark or 'tea colored' urine.*

FDA Label Image

Ertdf-figure-2.jpg (Ertdf Figure 2)

A bulleted list of potential side effects including diarrhea, nausea, tiredness, headache, dizziness, depression, trouble sleeping, abnormal dreams, and rash. The text appears to be from a medication information section outlining adverse reactions.*

FDA Label Image

Ertdf-figure-3.jpg (Ertdf Figure 3)

Label for Emtricitabine, Rilpivirine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/25 mg/300 mg, film-coated oral tablets. The label includes dosage strengths, storage instructions, manufacturer Laurus Labs Limited, and distributor Laurus Generics Inc. It also features an alert box advising pharmacists about contraindicated medicines. Package contains 30 tablets, Rx only.*

FDA Label Image

Ertdf-ril-structure.jpg (Ertdf Ril Structure)

Chemical structure of emtricitabine, rilpivirine and tenofovir disoproxil fumarate product showing a complex molecular diagram including aromatic rings and nitrogen atoms. The structure includes a hydrochloride component (HCl) indicated on the right side.*

FDA Label Image

Ertdf-teno-structure.jpg (Ertdf Teno Structure)

Chemical structure of emtricitabine, rilpivirine and tenofovir disoproxil fumarate components, focusing on the tenofovir disoproxil fumarate molecule. The structure includes phosphate and ester functional groups characteristic of this prodrug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.